InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by O'Keefe Kenneth W, Directeur. Insider active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 8 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €163k. History available since 29 July 2021. The latest transaction was disclosed on 2 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to O'Keefe Kenneth W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
603 股@ US$173.0715.0% 占其流量Ordinary SharesSEC:0001397661-25-000009:0
3,507 股0Ordinary SharesSEC:0001765581-25-000096:0
3,731 股0Ordinary SharesSEC:0001765581-24-000075:0
3,075 股0Ordinary SharesSEC:0001765581-23-000096:0
4,500 股@ US$81.7651.3% 占其流量Ordinary SharesSEC:0001765581-23-000034:0
2,561 股0Ordinary SharesSEC:0001765581-22-000092:0
1,306 股@ US$147.9627.3% 占其流量Ordinary SharesSEC:0001765581-21-000106:0
2,246 股0Ordinary SharesSEC:0001765581-21-000077:0
8 条申报中的 8 条
About O'Keefe Kenneth W
O'Keefe Kenneth W is Director of Jazz Pharmaceuticals plc (XNAS). He has filed 8 reports in total, and among the 8 most recent filings observed, the transactions cover the period from 2021-08-02 to 2025-12-04, with EUR 0 of purchases and EUR 163265 of sales; the most common transaction nature is Attribution.
